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Abstract
Environmental toxicants are ubiquitous throughout the environment as a result of
human activity. Among these toxicants, environmental estrogens are a category of
particular concern due to their environmental prevalence and potency in altering
reproductive traits. While many studies have addressed the detrimental effects of
environmental estrogens on both aquatic and terrestrial organisms, few have analyzed the
potential for these compounds to alter mitochondrial function. Mitochondria are the
primary energy-generating system for all eukaryotic life, supporting all aspects of
development, metabolism, and growth. Each cell within the body contains many
mitochondria which in turn contain multiple copies of their own DNA genome,
mitochondrial DNA (mtDNA). Mutations in mtDNA are responsible for a wide range of
human diseases such as metabolic syndromes, cancers, and obesity. Among these
mitochondrial diseases many are characterized by increased levels of heteroplasmy,
multiple mitochondrial DNA haplotypes within an individual. Increased heteroplasmy
can alter normal mitochondrial function and influence disease initiation and progression.
To date, no studies have investigated the effects of synthetic estrogens on
mitochondrial genome stability. Synthetic estrogens have the capacity to bind to estrogen
receptors and initiate estrogenic responses through translocation into the mitochondrion.
Despite our knowledge about the relationship of heteroplasmy and disease, we still do not
have a complete grasp of the mechanisms of heteroplasmic induction. Here we report our
analysis of the effects of 17α-ethynylestraiol (EE2) exposure in three studies to
investigate its effect on mitochondrial genome stability. Data analysis reveals a
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statistically significant relationship between EE2 exposure and increased heteroplasmic
frequency.
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Chapter I: Overview and Background
Mitochondria are vital intracellular organelles, central to most eukaryotic life.
They are best identified for their role in the production of cellular energy. This efficient
system coordinates energy production based on the availability of organic molecules and
oxygen to meet energy demands. They are also key to a continuum of other essential
cellular functions. Multiple cell wide stress responses are coordinated by mitochondria
and they play a principal role in both cellular life and cellular death. They support all
aspects of development, metabolism, and growth and are vital in the maintenance of adult
tissue homeostasis (Nunnari & Suomalainen, 2012; Youle et al., 2012).
Mitochondrial origins represent one of the earliest known symbioses occurring
>1.5 billion years ago between a proto-mitochondrion and a host prokaryote cell(Brown,
2008; Gray, 1999). This event marked the initiation and diversification of eukaryotic life
itself. Over time, this symbiosis evolved into an irreversible merger of mitochondria into
the host cytoplasmic organelle system and eukaryotes are marked by the co-occurrence of
two complete genomes, nuclear (e.g., host) and mitochondrial in animals. Genes with
duplicate function between symbiotic partners became redundant and as part of the
symbiotic inclusion process, the mitochondrial genome underwent a genome reduction in
animals either through gene transfer and/or loss of duplicate genes. This reduction in size
has resulted in extremely compact mitochondrial genomes, particularly in vertebrates,
with overlapping coding sequences essential to organelle function (Brown, 2008; Gray,
Burger, & Lang, 1999; Timmis, Ayliffe, Huang, & Martin, 2004).
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Structurally mitochondria have two membranes, an outer and inner, required for
normal function. The outer membrane encloses the entire organelle and contains a large
number of membrane proteins which allow smaller molecules and ions to pass freely to
the inner side of the outer membrane. The inner mitochondrial membrane is a highly
convoluted structure with folded invaginations, cristae, which increases the inner
membrane surface area. This membrane is highly impermeable and contains the
gelatinous matrix rich in ions, proteins, and enzymes involved in cellular metabolic
processes (e.g., tricarboxylic acid cycle). Also, embedded within the inner membrane are
numerous

protein

complexes,

sites

of

metabolic

pathways

(e.g.,

oxidative

phosphorylation) happening entirely or in-part within the mitochondria (Gray, 1999;
Schapira, 2006; Wallace & Fan, 2011).
Both the inner mitochondrial membrane and matrix are central to mitochondrial
metabolic processes. Of these, the most important is the synthesis of adenosine
triphosphate (ATP) through oxidative phosphorylation (OXPHOS). OXPHOS, the final
step in aerobic cellular respiration (Figure 1) generates a net 36 ATP at a cost of 1 glucose
molecule. Simplified, this process begins with the import of the glycolytic product
pyruvate into the mitochondrial matrix. Pyruvate is reduced to mitochondrial acetyl
coenzyme-A (acetyl coA), CO2 and NADH. From there, acetyl-coA enters the
tricarboxylic acid cycle (TCA cycle, i.e., citric acid or Kreb cycle) where it’s converted to
metabolic intermediates through a concentrated series of redox reactions, occurring
within the mitochondrial matrix. During the TCA cycle, the reduction of organic acid
intermediates produces excess NADH and FADH2 which are the predominant electron
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carriers used in the electron transport chain (Wallace, Fan, & Procaccio, 2011; Wallace &
Fan, 2011).

Figure 1: Schematic of cellular respiration. The glycolytic product pyruvate is imported into the
mitochondrial matrix, reduced acetyl coenzyme-A where it enters the citric acid cycle (TCA). During
the TCA cycle, acetyl CoA produces electron carriers used in the electron transport chain (within the
inner mitochondrial membrane), the site of oxidative phosphorylation producing a net 36 molecules of
cellular energy, ATP.

The electron transport chain is composed of a series of embedded inner
mitochondrial membrane protein complexes that work to transfer electrons with the
concomitant extrusion of proton ions. Working as electron carriers, NADH and FADH2
are oxidized as they supply electrons to O2. Protons are pumped out of the mitochondrial
matrix into the intermembrane space as electrons are passed along the transport chain.
This process creates an electrochemical gradient that results in energetically favorable
phosphorylation of ADP and phosphate into ATP as protons flow back into the
mitochondrial matrix (Figure 2). The highly impermeable inner mitochondrial membrane

3

is key in creating an electrochemical gradient between the matrix and intermembrane
space (Duchen, 2004; Nunnari & Suomalainen, 2012).

Figure 2: Schematic of electron transport chain showing the embedded inner mitochondrial membrane
proteins transfer of electrons and concomitant extrusion of protons. This processes creates an
electrochemical gradient that results in the phosphorylation of ADP and phosphate into ATP as protons
flow back into the mitochondrial matrix (Schapira, 2006).

In addition, other catabolic pathways contribute to the production of ATP within
the mitochondria through the catabolism of other macromolecules In the process of βoxidation, fatty acids are degraded in the mitochondria to generate acetyl-CoA units
which feed the TCA cycle. The mitochondrial enzyme pyruvate oxaloacetate is involved
in the conversion of metabolic intermediates involved in gluconeogenesis. Even
ketogenic processes occur entirely within the mitochondria during periods of high β-
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oxidative activity and low TCA activity where acetyl-coA is converted to ketone bodies
(Kroemer et al., 2012; Nunnari & Suomalainen, 2012).
Reactive oxygen species (ROS) are a normal byproduct of metabolic pathways
occurring within the mitochondria with the most prominent source being cellular
respiration. Excess production can cause oxidative stress resulting in damaged
mitochondrial proteins, lipids, and DNA. Damaged cellular components are causal to
metabolic dysfunction, alterations in membrane potential, and further increase the
production of ROS. These aberrant conditions can increase ATP consumption to
compensate for membrane potential deviations, further perpetuating adverse cellular
conditions. Repair and quality-control mechanisms safeguard mitochondria from the
detrimental or deleterious effects of oxidative stress. In response to genotoxic damages
caused by ROS, mitochondria initiate some forms of DNA repair pathways similar to
those in the nucleus (Gladyshev, 2013).
Normal mitochondrial activity is dependent on the functioning of over a thousand
proteins. These proteins are encoded mostly by genes within the nuclear genome
(nDNA); however, each individual mitochondrion contains multiple (i.e., between 5-10)
circular genomes necessary for its function. The mitochondrial genome (mtgenome or
mtDNA) is highly compact with no introns and very few intergenic spaces. In vertebrates,
it ranges from 15,000-17,000 kilobases (kb) in length and encodes for 37 genes necessary
respiratory chain activity and translation of mtDNA genes (Broughton, Milam, & Roe,
2001; Kelly & Scarpulla, 2004).

5

Given the central role in mitochondria in most cellular processes, impaired
mitochondrial function is causal to a variety of diseases. These phenotypes range from
alterations in cell function to cell death as a result of mutations in mtDNA. Mitochondrial
disease can be heterogeneous or multisystemic, but often preferentially affects tissues or
systems with high-energy demands including the brain, heart, muscle, digestive and
endocrine systems. Severity of disease states is often related to mtDNA copy number
(i.e., the proportion of mutated to wild-type mtgenomes). The mixture of mutant and
wildtype (i.e., normal) mtDNA genomes within a single mitochondrion, cell, tissue or
individual is termed heteroplasmy (Chan, 2006; Jayaprakash et al., 2014; Nunnari &
Suomalainen, 2012; Wallace & Chalkia, 2016).
Given mitochondria’s strict pattern of maternal inheritance, heteroplasmy can
occur from germ-line inheritance, (i.e., from oocyte cytoplasm), or arise as somatic
mutations (Brown, 2008). If a heteroplasmic oocyte is fertilized and forms a zygote,
during each cell division different mitochondrial genomes (i.e., heteroplasmy) can be
randomly distributed to the daughter cells and continue to be copied during each cell
cycle. Unequal distribution can contribute to mitochondrial disease initiation and onset.
When mutant mtDNA is inherited through oocyte transmission, the proportion of mutated
mtgenomes, as well as replication and distribution, is stochastic (Wallace & Fan, 2011).
Over many cell generations, heteroplasmy can increase (i.e., higher proportions of mutant
mtDNA) and consequently those cells undergo a decrease in the production of energy
(Wallace & Chalkia, 2016).

6

Somatic mutations can occur in mtDNA just as they do in nuclear DNA.
Mitochondria have a high mutation rate as they lack protective histones like nuclear DNA
and have only rudimentary repair mechanisms. Mitochondria undergo fission and fusion
events as a mechanism of redistribution to meet altered energetic demands but also to
selectively remove stressed or damaged organelles. MtDNA molecules exist in clusters
called nucleoids adjacent to the respiratory chain where they are prone to oxidative
nucleotide base damage from ROS byproduct production. Mutated mtgenomes have the
ability to expand clonally, eventually causing an energetic defect (Chandra & Singh,
2011; Schmitt et al., 2012).
Energetic defects in both inherited and somatic mutated mtgenomes have been
implicated in forms of blindness, deafness, movement disorders, dementias,
cardiomyopathy, myopathy, renal dysfunction and aging (Chan, 2006; Chandra & Singh,
2011). There is an ever growing list of disease phenotypes being characterized by
mitochondrial dysfunction with ill-understood patterns of disease initiation and
progression (Payne et al., 2013). Currently there is no pharmaceutical cure for any
mitochondria-related diseases (Nunnari & Suomalainen, 2012). With the severity of most
mitochondrial diseases states, this organelle is an emerging topic of study.
Although mitochondria have been studied as a therapeutic target (Wallace et al.,
2011), few studies have assessed the effects of environmental toxicants on mitochondria.
Environmental toxicants are ubiquitous in our environment with continuous release from
various sources including industrial and consumer activity (Meyer et al., 2013). Among
these, environmental estrogens are of particular concern given their prevalence in a wide
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range of products (i.e., pesticides, plastics, pharmaceuticals and household products) and
potent estrogenic activity that modulates and/or disrupts a variety of animal systems
(Hecker & Hollert, 2011; Tyler, Jobling, & Sumpter, 1998). Many studies have
demonstrated environmental estrogens induce physiological and developmental
dysfunction on both aquatic and terrestrial species at environmentally relevant
concentrations.
Two of the best exemplified studies are a 7-year whole lake experiment in
Ontario, Canada and the analyses of English river systems receiving effluent from
wastewater facilities. In the whole lake exposure Kidd and colleagues demonstrated that
chronic exposure of 17α-ethynylestradiol (i.e., synthetic estrogen) at environmentally
relevant concentrations led to the near collapse of the lake fathead minnow (Pimephales
promelas) population. The decline was linked to both the feminization of males, which
reduced levels of sperm production, and altered oogenesis in females, which resulted in
decreased offspring survival (Kidd et al., 2007).
Other studies investigating the impacts of estrogenic contaminants on aquatic
species have observed aneuploid sperm formation (Brown, Schultz, Cloud, & Nagler,
2008) and reduced embryonic survival following parental exposure in rainbow trout
(Brown, Schultz, & Nagler, 2007), reduced female reproductive success in zebrafish
(Coe, Söffker, Filby, Hodgson, & Tyler, 2010) and intersex males (i.e., phenotypic male
with gonads containing both testicular and ovarian tissue) in roach (Flores & Hill, 2008;
Tyler & Jobling, 2008). Such effects are not limited to aquatic organisms with similar
studies conducted in mice and rats having also shown developmental disturbances and
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reproductive anomalies including: reduced sperm counts in males (Takahashi & Oishi,
2006), increased oocyte aneuploidy (Susiarjo, Hassold, Freeman, & Hunt, 2007), reduced
sex accessory organ weights (Takahashi & Oishi, 2006), and disruptions in oogenesis
(Hunt & Hassold, 2008). Similar to the findings in aquatic vertebrates, many of the
observed detrimental effects in terrestrial models also occurred with environmentally
relevant doses.
Environmental estrogens, including synthetic estrogens and estrogen mimicking
compounds, are of particular concern due to their environmental prevalence and potency
in altering reproductive traits. Contaminants originate from a variety of sources with one
of the most prominent mechanisms of environmental release occurring through
wastewater effluent (Desbrow & Routledge, 1998; Hamid & Eskicioglu, 2012; Pollock,
Dubé, & Schryer, 2010; Ternes et al., 1999). Synthetic estrogens, such as 17αethynylestradiol (EE2), are widely used as pharmaceutical contraceptives for humans and
animals as well as for hormone replacement therapy for post-menopausal women (Rogan
& Gladen, 1985).
Vertebrate animals, including humans, primarily excrete estrogens through the
urinary system in a conjugated and biologically inactive form. This conjugated, inactive
form is highly soluble in water and easily transported in waste water. Despite this, the
active unconjugated form of estrogen is the dominant form found in the influent and
effluent of waste water treatment facilities. The process of converting the compounds
from inactive to active forms after excretion occurs through an enzymatic process with
bacteria de-conjugating the estrogens and converting them to their biologically active
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forms. This fluctuation between the inactive and active form of estrogen compounds
results in inaccurate detection and reduced efficacy of removal processes at waste water
treatment plants. Although these treatment facilities still reduce the concentrations
following waste water treatment, environmental estrogenic effects are still observed at
low doses on a variety of species (Ingerslev, Vaclavik, & Halling-Sørensen, 2003; Kolpin
et al., 2002; Schultz, Orner, Merdink, & Skillman, 2001).
Although there are clear indications that environmental estrogens have direct
effects on development and reproductive functions, few studies have analyzed the
potential for these compounds to alter mitochondrial genomic structure despite
mitochondria having the ability to bind estrogen. Endogenous estrogens bind to estrogen
receptors (ERs) eliciting complex cellular interactions through membrane, nuclear, and
mitochondrial signaling pathways (Ropero, Alonso-Magdalena, Ripoll, Fuentes, & Nadal,
2006). The import of ERs into the mitochondria (mtERs) allows them to modulate
estrogenic activity within mitochondria, coordinate mitochondria-nuclear regulatory
cross-talk, and affect overall concentration and distribution of anti-apoptotic proteins
(Kaipparettu et al., 2013; Spinazzola & Zeviani, 2007). An environmental estrogens
capacity to bind ERs and elicit estrogenic responses is subject to the chemical structure of
the foreign estrogen and ER binding affinities within target tissues (Shyu, Cavileer,
Nagler, & Ytreberg, 2011). 17-α ethynylestradiol (EE2) is a potent estrogenic compound
in many fish species with greater binding affinity compared to the endogenous estrogen
estradiol-17β (E2).
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Danio rerio, zebrafish, are a small freshwater tropical fish originating from East
India. Zebrafish have become a valuable vertebrate model organism used in various areas
of study; developmental, reproductive, genetic, toxicological, and biomedical (Brown et
al., 2012; Soares et al., 2009). There are multiple advantages to using zebrafish as a study
model compared to other common vertebrate models (e.g., mice). Among these, the most
obvious are that zebrafish are relatively inexpensive to maintain, produce a large number
of offspring per mating and have a rapid generation/gestation period. Zebrafish embryos
develop outside of the mother and development processes are fairly visible due to the
transparency of the egg membrane.
In zebrafish, both the nuclear and mitochondrial genomes have been fully
sequenced (Broughton, Milam, & Roe, 2001). The use of zebrafish in studies
investigating the mitochondrial genome is particularly useful because of its many
commonalities to other vertebrates. Zebrafish mtgenome gene order and content are
identical to the majority of vertebrates, including humans, making them a valuable tool
for studying mitochondrial disease states (Howe et al., 2013).
Lastly, several laboratory strains of zebrafish exist which are useful in
understanding heterogeneity (Gladyshev, 2013). Of these strains, the three most common
laboratory strains include AB, Tu, and WIK. Each strain differs in their initial
development and historic degree of selective breeding. Continued examination of mtDNA
variation between strains is necessary for future work using zebrafish as a model given
mtDNA strain variation may have a role in interstrain phenotypic variation.
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To date, no studies have assessed the potential for induced heteroplasmy as a
result of environmental estrogen exposure. Given that environmental estrogens have the
potential to cause incidental mitochondrial genomic damage following exposure via
binding to estrogen receptors and translocation into the mitochondrion (Menuet et al.,
2004), we investigated the effects of 17-α ethynylestradiol (EE2) exposure on
mitochondrial

genome

stability.

The

following

studies

investigated

whether

mitochondrial heteroplasmy can result from non-native estrogen exposure in fish through
the following aims: (1) preliminary assessment of short-term EE2 exposure on aged
isogenic male trout mitochondrial DNA, (2) acute EE2 exposure effects on mitochondrial
DNA during sexual differentiation on full-sib offspring using three strains of zebrafish
with comparisons to baselines rates from aged strain specific fish and (3) assess the
effects of chronic EE2 exposure on mitochondrial DNA during full-sib offspring
development in three strains of zebrafish.
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Chapter II: Preliminary study on trout
Introduction
Environmental estrogens are a potent class of toxicants found ubiquitously in our
environment as a result of their wide range use in commercial and industrial products
including pesticides, plastics, and pharmaceuticals (Fenske, Maack, Schäfers, & Segner,
2005; Ropero et al., 2006). Environmental estrogens present a significant health concern
as numerous studies have demonstrated synthetic estrogens modulate and/or disrupt a
variety of animal systems (Hecker & Hollert, 2011). Such studies demonstrating
physiological and developmental dysfunction on both aquatic and terrestrial vertebrate
species within environmentally relevant concentrations include: reduced sperm
production, altered spermantogenesis, intersex and complete feminization of males,
altered female oogenesis and induction of aneuploidy in both sexes (Brown et al., 2008;
Hunt et al., 2003; Kidd et al., 2007; Schultz, Skillman, Nicolas, Cyr, & Nagler, 2003;
Takahashi & Oishi, 2006; Tyler & Jobling, 2008).
While naturally occurring estrogens bind to estrogen receptors (ERs) and elicit a
complex range of cellular actions through membrane, nuclear, and mitochondrial
signaling pathways, the capacity of synthetic estrogens to bind to ERs and initiate an
estrogenic response is subject to the chemical structure of the foreign estrogen and ER
binding affinities in the target organs (Menuet et al., 2004). The most commonly used
synthetic estrogen, 17-α ethynylestradiol (EE2), is found in most contraceptive products
and hormone replacement therapies. EE2 has been demonstrated to be more potent than
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the endogenous estrogen, estradiol-17 β (E2), in many fish species with a greater
estimated binding affinity (Shyu et al., 2011).
Mitochondria as targets of environmental toxicants is gaining increased
recognition (Meyer et al., 2013). Assessing the impact of synthetic estrogens on
mitochondrial integrity is significant given the import of ERs into the mitochondria
(mtERs) modulates estrogenic activity within the mitochondria and coordinates
mitochondria-nuclear regulatory cross-talk. The importance of mitochondria cannot be
understated as they are vital subcellular organelles key to all aspects of development,
metabolism and growth (Nunnari & Suomalainen, 2012; Youle et al., 2012). They are
responsible for cellular life-death decisions and also play critical roles in other
physiological processes (Cheng & Ristow, 2013).
One significant factor in mitochondrial function is their genetic material,
mitochondrial DNA (mtDNA) with all mitochondria having multiple copies of the
genome within each organelle (Falk et al., 2014). MtDNA can have increased
susceptibility to environmental genotoxins as a result of their physical location near
reactive oxygen species (ROS) production sites, reduced protein packing and reduced
repair capacity. Mutations within the mtDNA are known to cause a wide range of
physiological disorders including: neurodegenerative disorders, cardiomyopathies,
metabolic syndromes, cancer, obesity and premature cell senescence (Goldstein, Bhatia,
& Vento, 2013; Schapira, 2006; Wallace & Chalkia, 2016). Disease phenotype and
severity is often dependent on the proportion of wild type and mutant mtDNA within an
individual, or mtDNA heteroplasmy. While many mitochondrial related disease states are
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strictly hereditarily acquired, to date no studies have assessed the potential for induced
heteroplasmy as a result of environmental estrogen exposure.
The following study is a preliminary investigation assessing the effects of shortterm EE2 exposure on mtDNA stability in sexually mature male isogenic rainbow trout.
Methods
The following was done at the Pacific Northwest National Laboratory in
accordance to the guidelines established by the Institutional Animal Care and Use
Committee (IACUC). Male isogenic rainbow trout (O. mykiss) hybrid clones (OSU X
Swanson) were obtained from Washington State University and reared to 32 months of
age in circular 1,400-L tanks under pass flow-through freshwater system with in-flow
rates between 15-20L/min (Young & Wheeler, 1992). Water was sourced from Battelle
Marine Science Laboratory’s artesian well (depth = 134m) in Sequim Washington and
aerated before transfer to holding tanks. Tank quality parameters were routinely measured
in all tanks and include: temperature (mean: 11.2 oC; range: 10.9 – 11.4 oC), dissolved
oxygen (>9 mg/L) and pH (mean 7.9; range: pH 7.8 – 8.1). Trout were fed a moist 26mm pellet feed from Vitalis Bio-Oregon Inc. (Longview, WA USA) at a ration level of
approximately 0.75% body mass to encourage growth. Trout were maintained under
lighting that simulated a natural photoperiod that included a 12-minute graded sunrise
and sunset period.
The 17 α-ethynylestradiol was purchased from Sigma-Aldrich. All other
chemicals were reagent grade. At 32 months of age, trout were exposed to 17αethynylestradiol using a continuous flow protocol for fifty (50) days. Exposure solutions
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were prepared and added slowly using a peristaltic pump. Exposure tanks were
equilibrated for three days prior to fish exposure. Trout were exposed to a nominal EE2
exposure level of 10ng/L. Control trout were unexposed to EE2 but handled and
maintained as those under treated fish conditions.
After fifty days exposure, trout were euthanized using MS-222 by anesthetic
overdose. Livers were excised immediately following death and rinsed with cold buffer
solution described by Frezza (Frezza, Cipolat, & Scorrano, 2007).
Liver tissue was homogenized using glass Teflon homogenizers performed at 4°C
to minimize damage caused by phospholipases and proteases. A two-phase sucrose
gradient differential centrifugation to enrich for functional mitochondria was performed.
The first phase isolated cellular debris through low speed centrifugation while the second
isolated mitochondria through high speed centrifugation (Frezza et al., 2007).
Mitochondrial DNA was extracted from the pellet using DNeasy Blood & Tissue Kit
(QIAGEN) following standard tissue protocols.
Nucleic acid quantification was performed using NanoDrop 2000 UV-Vis
Spectrophotometer. Using two mitochondrial specific primers and one nuclear specific
primer, we assessed the proportion of mtDNA to nuclear DNA. Genes were amplified in
10µL reaction mixtures (Taq DNA polymerase, forward and reserve primers and BSA)
containing: 1µL DNA template, concentration range 55-90ng/µL).
Extracted DNA was sent to Oregon Health and Science University’s Massively
Parallel Sequencing Shared Resource (MPSSR) for library preparation, barcoding, and
sequencing. Sequencing was performed using the Illumina HiSeq 2000 Sequencer.
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Using Bowtie 2 v2.1.0, we mapped sequence reads against trout mitochondria
reference genome (accession L29771) using default indexing parameters. Raw paired-end
sequence data were mapped to each index using default alignment parameters in Bowtie
2 v2.1.0. Using Bowtie2 SAMtools we generated a binary BAM format, sorted the BAM
file and ran mpileup to produce a format of each line representing a genomic position. A
Python script was used to convert to data files which were accessible for further analysis
of frequency of nucleotides diversity per site.
Results and Conclusions
We used PCR amplification to assess for genomic DNA contamination and verify
enrichment of mtDNA content post organelle isolation on one EE2 treated sample, 107
and one control sample, 105.1 (Figure 3) against a test sample of total Swanson Clone
DNA. Mitochondrial enrichment proved highly successful with little to no detectable
nuclear DNA present in amplification.
Three fish treated at 10ng EE2/L and three untreated controls were used for
comparison. We achieved an overall coverage of 8000x across all samples sequenced. We
defined heteroplasmy as the second most common base variant per site across the
mitochondrial genome. A sequencing error rate of 0.0004 or 0.04% was determined by
comparing sequencing replicates of one control sample through the difference between
the absolute value of heteroplasmic frequency between each site and determining the
average across the genome. A linear regression comparing heteroplasmy between
sequencing replicates demonstrated high consistency in same lane sequencing as seen
with a R2 of 0.9939 (Figure 4).
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We established a conservative threshold of heteroplasmic calls to be ≥0.25% or 5x
our sequencing error rate. Heteroplasmic calls were not found to be statistically
significant between treated and control fish (Figure 5) although there was an increase in
the number of heteroplasmic sites in almost all EE2 treated fish compared to the control
(Table 1). Out of all EE2 treated fish, the lowest number of sites considered
heteroplasmic is slightly greater than the highest number of sites in the control fish.
Using UCSC Genome Browser to map heterplasmic sites to the mitochondrial genome,
and observed site specific mutations in EE2 treated fish compared to the control (Figure
6).
We found consistency between sequencing replicates demonstrating low
sequencing error rate when using Illumina Next-Generation Sequencing technology.
Although we achieved high depth of coverage, 8000x in our approach for mtDNA
enrichment, we desired greater coverage for our subsequent experimental treatments to
ensure greater confidence in determining heteroplasmic calls. Even with our low sample
size, n=3 per group, we see site specific mutations and an overall increase in
heteroplasmy between treated and untreated fish. This preliminary study provided a base
for improving technique and supports continued investigation of assessing whether
treatment of EE2 can increase heteroplasmic frequency in mtDNA.
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Figures and tables

Figure 3: PCR amplification assessing genomic DNA contamination
after mitochondrial organelle isolation in EE2 treated trout sample,
107 and control sample, 105.1 against test sample SW containing total
DNA.

Figure 4: Linear regression of heteroplasmy between sequencing replicates in trout
control sample.
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Figure 5: Average number of heteroplasmic sites ≥0.25% between EE2 treated (red) and
control (green) trout (p>0.05).

Table 1: Heteroplasmic sites ≥0.25% in
EE2 treated vs control trout samples
Heteroplasmic
Sample ID
sites ≥ 0.25%
cntrl102-2_rep1
644
cntrl102-2_rep2
707
cntrl105-1
734
cntrl105-2
652
EE2 107
710
EE2 104-1
1015
EE2 104-2
650
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Figure 6: Mutational frequencies ≥0.25% viewed in UCSC genome browser in control (green) and EE2
treated (red) trout across the whole mitochondrial genome (top) and zoomed into positions 9-9.5K.
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Chapter III: Acute treatment study and baseline comparisons
Introduction
Environmental estrogens are a potent class of toxicants found ubiquitously in our
environment as a result of their wide range of uses in commercial and industrial products
including pesticides, plastics, and pharmaceuticals (Fenske et al., 2005; Ropero et al.,
2006). Environmental estrogens present a significant health concern as numerous studies
have demonstrated synthetic estrogens modulate and/or disrupt a variety of animal
systems (Hecker & Hollert, 2011). Such studies demonstrating physiological and
developmental dysfunction on both aquatic and terrestrial vertebrate species within
environmentally relevant concentrations include: reduced sperm production, altered
spermantogenesis, intersex, complete feminization of males, altered female oogenesis and
induction of aneuploidy in both sexes (Brown et al., 2008; Hunt et al., 2003; Kidd et al.,
2007; Schultz et al., 2003; Takahashi & Oishi, 2006; Tyler & Jobling, 2008).
While naturally occurring estrogens bind to estrogen receptors (ERs) and elicit a
complex range of cellular actions through membrane, nuclear, and mitochondrial
signaling pathways, the capacity of synthetic estrogens to bind with ERs and initiate an
estrogenic response is subject to the chemical structure of the foreign estrogen and the ER
binding affinities in the target organs (Menuet et al., 2004). The most commonly used
synthetic estrogen, 17α-ethynylestradiol (EE2), is found in the majority of contraceptive
products and hormone replacement therapies. EE2 has been demonstrated to be more
potent than endogenous estrogen, estradiol-17 β (E2), in many fish species with a greater
estimated binding affinity (Shyu et al., 2011).
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Mitochondria as targets of environmental toxicants is gaining increased
recognition (Meyer et al., 2013). Assessing the impact of synthetic estrogens on
mitochondrial integrity is significant given the import of ERs into the mitochondria
(mtERs) modulates estrogenic activity within the mitochondria and coordinates
mitochondria-nuclear regulatory cross-talk. The importance of mitochondria cannot be
understated as they are vital subcellular organelles key to all aspects of development,
metabolism and growth (Nunnari & Suomalainen, 2012; Youle et al., 2012). They are
responsible for cellular life-death decisions and also play critical roles in other
physiological processes (Cheng & Ristow, 2013).
One significant factor in mitochondrial function is their genetic material,
mitochondrial DNA (mtDNA) with all mitochondria having multiple copies the genome
(Falk et al., 2014). MtDNA can have increased susceptibility to environmental genotoxins
as a result of their physical location near reactive oxygen species (ROS) production sites,
reduced protein packing and reduced repair capacity. Mutations within the mtDNA are
known to cause a wide range of physiological disorders including: neurodegenerative
disorders, cardiomyopathies, metabolic syndromes, cancer, obesity and premature cell
senescence (Goldstein et al., 2013; Schapira, 2006; Wallace & Chalkia, 2016). Disease
phenotype and severity is often dependent on the proportion of wild type and mutant
mtDNA within an individual, or mtDNA heteroplasmy. While many mitochondrial
related disease states are hereditarily induced, to date no studies have assessed the
potential for induced heteroplasmy as a result of environmental estrogen exposure.
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The goal of this study was to examine the effects of EE2 on mitochondrial
genome stability after acute exposure to zebrafish during the bio-energetically demanding
period of sexual differentiation. In addition, we assessed the effects of EE2 on the
proportion of females between untreated fish and treatment groups, tracking survivorship
between environmentally relevant treatment concentrations. Lastly, because mitochondria
is maternally inherited, we used the maternal lines for comparison of full-sib treatment
groups as well as fish for baseline comparison from each strain to assess standing rates of
heteroplasmy.
Methods
All fish were maintained in accordance to guidelines established by the
Institutional Animal Care and Use Committee (IACUC) of Portland State University.
Adult male and female zebrafish, of the three common laboratory strains AB, Tu, and
WIK, less than one year of age were obtained from the Zebrafish International Resource
Center (ZIRC) for use as either baseline analysis fish, maternal lines or for the generation
of full-sib treatment groups. Fish were housed in 2.8-liter baffled flow-through tanks at a
ratio of 1 male: 1 female with a stocking density of 10 or less fish per 2.8L tank in the
Brown Zebrafish Aquatics Facility at Portland State University. Fish were maintained on
the Aquaneering Modular System with 4-stage central filtration providing continuous
flow-through of recirculating water with a twice daily automated 10% water change. This
system monitors and maintains parameters within a narrow range to ensure
environmental effects are negligible. The aquatic facility utilizes a photo period of 15h
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light: 9 hr dark. Adult fish were fed two times a day ad libitum with larvae power and live
Artemia salina (brine shrimp).
Sexually mature zebrafish used for generation of treatment fish were set up as
breeding pairs (1 male:1 female) in Aquaneering Crossing Tanks with dividers to separate
each pair. The following morning, dividers were removed and zebrafish were allowed to
spawn for up to 6 hours. Spawning occurred within the aquatic facility under standard
room and system parameters.
Embryos were collected, rinsed with embryo media (Cold Harbor Springs 60x
recipe), and kept at a stocking density of ≤50 embryos per petri dish in media at 28°C for
5 days. At 5 days post fertilization (dpf) hatched larvae were transferred to static tanks
containing ~250mL media with water changes performed daily. Larvae were fed
concentrated rotifers twice daily ad libitum. At 9dpf larvae began transition to live brine
shrimp in addition to rotifers. At 11dpf larvae were transferred to the main system and
placed under a slow drip of ~1 drop/second. Larval powder was introduced at 14 days
and fish were transitioned to an adult feeding schedule at 3 weeks of ago. Juveniles were
raised under these conditions until 6 weeks of age for exposure initiation.
The exposure system (Figure 7) was designed and built in house. 20-gallon fish
tanks were used as common mixing tanks (x4 treatment groups) and 1 gallon fish bowls
were used as treatments tanks to house respective pair/strain/treatment type (2 pairs per
strain, 3 strains). Using PVC piping and a centrifugal pump, pre-mixed exposure water
was routed circularly with an inflow ball valve into 1 gallon fish bowls. Each exposure
tank had an outflow valve routed into a common waste basin which was pumped through
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a triple filtration system before flowing into the common building drainage and city
wastewater system. Common mixing tanks were spiked with EE2 or methanol (for
control) and allowed to equilibrate for 24 hours prior to transfer of juvenile fish.
The test compound 17α-ethynylestradiol (EE2) was obtained from Sigma-Aldrich
( ≥ 98% purity grade). EE2 was solubilized in 100% methanol at a ratio of 1mg/1mL. A
final working concentration of 10ng EE2/µL in 10% methanol was prepared as the final
exposure working stock for spiking treatment water. Control fish were exposed to
methanol at the highest EE2 treatment concentration, 9.5µL methanol/gallon tank water
or ≤0.00025%.
At 6-weeks of age, following sexual differentiation, juvenile zebrafish (Danio
rerio) from strains AB, Tu, and WIK were exposed for 6 weeks to nominal values of 10ng
EE2/L, 100ng EE2/L, and 250ng EE2/L (Figure 8). Control fish were exposed to
≤0.00025% methanol, equivalent to the greatest amount of methanol used on the 250ng
EE2/L treated fish. Two sets of full-sib juveniles were used for each strain totaling six
families per treatment type.
Two acute treatment series were performed (acute exposure (1) and acute
exposure (2)). During the initial trial, an immediate die-off of juvenile fish was observed
and discovered to be a result of low water conductivity, 0.02ppt. Initial common mixing
tank water was sourced from the main system’s fresh water sump after dechlorination
which reduced ions levels below acceptable levels. Hours into the initial exposure, 2ml
NaCl/gallon was added to common mixing tanks. Thereafter, each common mixing tank
fill included 2ml NaCl per gallon of water. We had a target of 20 individuals per pair and
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treatment. For the duration of the treatment, exposure water was semi-static with daily
30-second flushes per bowl.
Baseline fish were also tested to establish nominal background rates of
heteroplasmy between strains. Ten adult zebrafish (5 females and 5 males) from each of
the three strains were raised under standard rearing conditions to 2 years of age, as
described above. Assessment of these fish will ensure that baseline heteroplasmic
frequencies are similar between untreated and methanol only treated individuals as well
as for comparison of between strain variations.
Fish were euthanized using MS-222 (Sigma-Aldrich) at a concentration of
300mg/L water at pH 8 for ≥15 minutes. Weight and sex was recorded prior to liver
extraction. Liver tissue was collected from zebrafish by surgical manipulation under a
stereoscopic microscope (Leica Microsystems) and stored at -20°C until further use.
Total DNA was isolated from liver tissue using QIAGEN DNeasy Blood & Tissue
Kit. Nucleic acid quantification was performed using NanoDrop 2000 UV-Vis
Spectrophotometer. To assess for mtDNA in total DNA, two primer pairs of
mitochondrial encoded protein subunits for cytochrome b and one primer pair of nuclear
encoded protein subunit for rhodopsin were used. Genes were amplified in 10µL reaction
mixtures (Taq DNA polymerase, forward and reserve primers and BSA) containing: 1µL
DNA template, concentration range 55-90ng/µL.
We used custom designed Agilent SureSelectXT Target Enrichment Kit for
Illumina Multiplex Sequencing to capture the following 5 genomic regions of interest:
mitochondrial

genome

(1-16596bp),

chromosome
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(9838621-9841031bp),
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chromosome 22 (17417393-17419398bp), chromosome 22 (17422326-17422970bp) and
chromosome 7 (31329397-31333402bp). Four probes were designed for regions of the
nuclear genome, three for mitochondrial encoding nuclear genes (ndufv1 - NADH
dehydrogenase of complex I, and two regions ATPAF1 - assembly factor of ATP
synthase) and one for a non-mitochondrial related nuclear encoded gene (isl2b - insulin
gene enhancer protein).
Paired-end Illumina libraries were captured in accordance to the SureSelect
protocol with the following modifications. Input DNA and buffer for fragmentation was
doubled to 6µg DNA into 260µL total volume 1x TE buffer. Sonication was performed
for a median fragment target size of 150-200bp on Cole-Parmer Ultrasonic Processor at
60% amplitude, for a total of 4.5 minutes sonication time with on-off intervals of 9-30
seconds on and 8-30 seconds off. For the first sample purification step using Agencourt
AMPure XP beads, input bead volume and concentration of sheared DNA library was
doubled. The products were end-repaired, 3’non-template A’s were added, and pair-end
adapters were ligated. Ligated libraries were PCR amplified for 6 cycles.
DNA libraries were hybridized to custom biotinylated probes with subsequent
immobilization on magnetic beads. After elution of the captured target regions, libraries
were amplified with 1 of 16 unique index primer tags for each sample in accordance to
intra or inter lane sequencing design.
Quantification and quality assessment of indexed-captured libraries was done
using Agilent 2100 Bioanalyzer and qPRC at Oregon Health and Science University’s
Massively Parallel Sequencing Shared Resource (MPSSR). Index-tagged libraries were
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pooled for multiplexed sequencing. Using the Illumina HiSeq 2000 Sequencer, 100-bp
paired-end reads were generated for each sample.
Using Bowtie 2 v2.1.0, we prepared three indexes for reference using default
indexing

parameters.

For

the

zebrafish

mtDNA

reference,

GRCz10

(GB

GCA_000002035.3) was used to prepare the first index (mtDNAindex). Because the
mtgenome is a circular molecule, we prepared a 936bp long concatenated index
(concatenated_mtDNA_index) by manually clipping the first 456 bp and last 480 bp
locations and wrapping them to close the genome. A third index was created using the
zebrafish reference Zv9 (GCA_000002035.2) by selecting out the nuclear target regions
per probe design. The GRCz10 reference release is an improved assembly of Zv9 which
was a preliminary assembly; however MT assemblies are identical within the two
versions. The Zv9 assembly was used as an index to our nuclear probes based on the
design date of our probes being prior to the release of the revised assembly.
Raw paired-end sequence data were mapped to each index using default
alignment parameters in Bowtie 2 v2.1.0. Using Bowtie2 SAMtools we generated a
binary BAM format, sorted the BAM file and ran mpileup to produce a format of each
line representing a genomic position. A Python script was used to convert to data files
which were accessible for further analysis of frequency of nucleotides per site.
Exposure water samples (400mL) were collected weekly throughout the duration
of the exposure. Control water samples (400mL) were collected at the half-way and final
week time points of the exposure duration. Both exposure water and control samples
were immediately spiked with internal standard (50ng IS/L). Samples were stored at -
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20°C until further analysis. Samples were thawed to room temperature 24 hours prior to
sample preparation for quantification.
Compounds used for LC-MS analysis include the following: triethylamine (TEA)
and 17α-ethynylestradiol (EE2) were obtained from Sigma-Aldrich. Acetonitrile (ACN)
and water (LC–MS grade) were from Burdick and Jackson (Muskegon, MI). 17βEstradiol-16, 16, 17-d3 (E2D3) was from Toronto Research Chemicals Inc.
Quality control samples were generated at concentrations of 10, 100, and 250ng
EE2/L using dilutions of authentic standard in methanol as in those used to spike
common mixing tanks. Calibrators were generated to cover the concentration range of
EE2 in mixing tank water from 1ng-250ng EE2/L using dilutions of authentic standard
dried and reconstituted in mobile phase.
D3 tagged estradiol (E2D3) was used as an internal standard (20μL at 1ng/µL) in
100% methanol added to QC samples, samples and calibrants. 400mL samples or QC
samples were passed through a 3mL Oasis HLB SPE cartridge (Waters) conditioned with
3mL of methanol using a vacuum manifold. Analytes were eluted using 2mL methanol,
dried under a vacuum, and reconstituted in 100µL starting mobile phase.
LC–ESI-MS analyses were performed using a high-resolution (30,000) Thermo
LTQ-Orbitrap Discovery hybrid mass spectrometry instrument (San Jose, CA) equipped
with an electrospray ionization source operating in the negative mode. The ESI interface
using the following settings: sheath gas flow rate 40 (arbitrary units), aux gas flow rate 15
(arbitrary units), spray voltage 2kV, capillary temperature 250C, capillary voltage -17 V,
and tube lens voltage -85 V. The Orbitrap was externally calibrated prior to data
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acquisition allowing accurate mass measurements for [M+H]+ or [M-H]- ions to be
obtained to within 4ppm.
The Orbitrap was coupled to a Thermo Accela HPLC system. EE2 was resolved
using a Kinetex C18 (4.6x50mm, 2.1 mm i.d., 2.5uL particle size) HPLC column with
guard cartridge (Phenomenex; Torrance, CA). Mobile phases consisted of 0.025% TEA in
HPLC grade water (A), 0.025% TEA in 95:5 methanol:water (B). The gradient mobile
phase was delivered at a flow rate of 0.3 mL/min and the TEA:water mobile phase.
Start conditions were 5% B, increased to 40% B over 2 minutes, increased to 45%
B over the next 5 minutes, 100% B over the next three minutes. Column was washed at
100% B for 1 minute and back to 5% B for 5 minutes. The column temperature was kept
at 25°C using a thermostatic column oven. The sample injection volume was 50 μL.
Results and Conclusions
We exposed 6 groups of full-sib offspring from 3 strains of zebrafish: AB, Tu, and
WIK, across 4 treatment categories: 10ng, 100ng, 250ng EE2/L and control (methanol
≤0.00025%) to assess the effects of EE2 on mitochondrial genome stability during sexual
differentiation, 6 weeks of age. We observed lethality among 100ng and 250ng EE2/L
treatment groups limiting our sequencing comparisons to the control and 10ng EE2/L
treatment group. We used Illumina next generation sequencing technology for sequencing
ultra-pure mtDNA after target enrichment from liver tissue of acute exposure (2) study
groups (Table 2): (a) 10ng EE2/L and control (at ≤0.00025% methanol) for 6 weeks, from
three strains of zebrafish AB, Tu, and WIK, using two separate maternal/paternal (1-1ab,
8-3ab, 2-1tu, 7-3tu, 1-1wik, 1-2wik) lines per strain; (b) the maternal line, as above, from
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each pair used to generate full-sib offspring for treatments; (c) 10 baseline fish (5 males
and 5 females) over 2 years of age from each strain; and lastly, (d) five replicate samples
(not in table) from each representative group to correct for sequencing error.
Actual start counts consisted of 13-23 acute exposure (1) and 18-21 acute
exposure (2) due to natural die off during the first 6 weeks of rearing in untreated system.
We were interested in comparing the survivorship of each treatment type (10ng, 100ng,
and 250ng EE2/L) to control (≤0.00025% methanol) using three zebrafish strains (AB,
Tu, and WIK) (Figure 9-12, top from acute exposure (1) and bottom from acute exposure
(2)). During the initial acute exposure (1), we had 2 issues: (a) initial counts were lost
because of recording errors, (b) rapid initial die-off within all treatment and control
groups predominantly in strain Tu. Survival curves from acute exposures (1) which begin
past day 0 show the first day of accurate counts for the associated strain and treatment
type recorded (e.g. acute exposure (1) 250ng EE2/L, TU-1 begins at 76% on day 14,
meaning between day 0-14 seven individuals were lost without record of individuals lost
per day). The rapid die-off was quickly discovered to be the result of low conductivity in
sourced water as described in the methods. The general trend seen from the acute
exposure (1) after initial die-off and start of survival counts was found to be 95% or
greater survival in the control and 10ng EE2/L groups across all three zebrafish strains
and 50% survival or less across all three strains of 100 and 250ng EE2/L treatment
groups.
Survivorship for acute exposure (2) series had similar patterns to exposure (1).
Greater than 95% survival was seen in all pairs and strains in the control group of acute
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exposure (2) with the exception of Tu pair 2.1; however, 30% loss in this pair/strain
occurred within the first 2 days of the exposure start date and remaining die-off, 5%
occurred within the first 4 days of exposure start which was likely associated with
acclimation sensitivity following tank transfer. Post-day 4, Tu 2.1 had 100% survival. All
pair and strains within 10ng EE2/L treatment had greater than 90% survival lacking any
indication of lethality at this concentration. As seen in acute exposure (1), both 100ng and
250ng EE2/L were found to be lethal in all 6 pairs used with the exception of WIK 1.1 at
100ng EE2/L which concluded the treatment at 55% survival. Phenotypically, surviving
individuals in 100ng and 250ng EE2/L treatment groups were greatly reduced in size and
weight, had a great degree of ascites, raised scales, and in some cases bulging eyes, and
enlarged hearts suggesting severe impairment of growth and developmental pathways and
inhibition of normal organ function.
Until 2013, sexual determination and differentiation pathways in zebrafish were
considered mostly unknown. Liew and Orban (2013) did an overview of zebrafish sex in
two strains of zebrafish (AB and Singapore based wildtype) where they identified three
major developmental pathways associated with gonad differentiation but concluded
further analysis is necessary to elucidate this process. With sexual differentiation
occurring 21-30 dpf (Liew, Bartfai, Lim, Sreenivasan, & Siegfried, 2012), and our
exposures beginning following sexual differentiation, 42 days of age, we were interested
in evaluating sex ratios in EE2 treated compared to control fish (Liew et al., 2012; Liew,
2013).
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The proportion of females post-42 day acute exposure (2) between control and
treatment (Figure 13) was not statistically significant; however, an increase was observed
in the proportion of females in 10ng EE2/L compared to controls. In the 100ng and 250ng
EE2/L treatment groups of each strain and pair, either 0% survival occurred or among the
few surviving individuals (≤55%), gonad type could not be determined from gross
dissection. This appeared to be due to stunted growth and severe fluid within the body
cavity.
Calibration curves were generated by performing a least-square linear regression
for peak area ratios (EE2 analyte/E2D3 internal standard) plotted against specified
calibrant concentration in water (ng/L). The lower limit of quantification (LLOQ) was
determined as the lowest concentration for which the signal-to-noise (S/N) ratio was ≥5
and the within- and between-day reproducibility of the peak area was ≤20% relative
standard deviation (RSD). For all other calibrators the between and within-run precision
(RSD) for calculated concentration across the range 1-250ng/L was ≤15% and accuracy
was within ±15% (detailed precision and accuracy information for calibrators and low
and high QCs provided in Table 3).
The goal of these experiments was to validate that the measured concentration of
common tank exposure water to treatment groups was within +/- 25ng EE2/L of spiked
concentration. The data we generated supported this (Table 4), calculated mean
concentrations of EE2 in mixing tank samples. In addition, EE2 was not detected in the
control samples taken from the half-way and end-of-exposure time points of acute
exposure (2) showing control fish were not exposed to EE2.
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Total DNA was isolated from liver tissue and quantified as described in the
methods with the following two exceptions: (a) the maternal fish from 2-1tu (pair 2-1,
strain Tu) died of natural causes while on the main aquatic system and upon retrieval,
adequate DNA for sequencing preparation was not successfully extracted from either
liver tissue or through fin clip attempts, (b) maternal fish from 8-3ab (pair 8-3, strain ab)
died of natural causes on the main aquatic system; however, adequate DNA was extracted
through superior anal fin clip opposed to liver extraction. Because mitochondria are
maternally inherited the loss of 2-1tu maternal DNA resulted in the exclusion of 2-1tu
control (M1-M6) and treated fish (10.1-10.6) from the analysis of sequence data.
All samples were assessed through gel electrophoresis post-sonication to ensure
target fragment size of 150-200bp or larger was achieved (Figure 14). During the initial
stages of working through the protocol, select samples were assessed for quality control
post-sonication and post-AMPure bead clean-up 1 but prior to library preparation using
Agilent 2100 BioAnalyzer (Figure 15). Samples were quantified using 1µl DNA at each
step of the library preparation protocol to ensure adequate DNA content was being
carried through the procedure.
Using target enrichment we achieved an average sequence coverage of >88,900x
across our entire sequencing project (Tables 5-9). Over 70% of samples sequenced with
an average coverage >90,000x. The lowest coverage within samples was >1000x at sites
profiled within the D-loop (between 1-950bp). Overlaid sequence coverage of replicate
samples demonstrates coverage across the mitochondrial genome and specific regions of
high vs low coverage. These replicates demonstrate that seen across all sequenced
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samples. Overall read counts and alignment to the mitochondrial references genome
ranged from 6-75million reads and 70.17-98.85% (table 10-14). Of these, 92% of
sample’s reads mapped at ≥90% and 81% of sample’s reads mapped ≥95% to the
reference mtgenome.
We achieved ultra-high coverage by using target enrichment to select for pure
mtDNA; however, sequencing error still presents as a challenge of modern sequencing
technologies. To establish a robust sequencing error rate we used a conservative strategy
of 5 replicate sample comparison, two within the same lane and three between lanes. To
ensure we accurately captured an error rate representative of all sample types, we
sequenced replicates from each group within our study: 1-methanol control, 2-10ng
EE2/L treated fish, 2-baseline fish and of these, at least one from each strain was used as
a replicate as demonstrated in overlaid sequence coverage (Figure 16). In addition, we
sequenced replicates of full sibs from control and treated fish as well. A linear regression
performed on one of each sample and comparability of between and same lane
sequencing shows consistency between samples (Figure 17).
We defined a heteroplasmic site as the number of calls for the second most
common allelic variant out of all calls for that site. Our standard for determining error in
each replicate sample was set by finding the heteroplasmic frequency of each site in both
replicates, subtracting the absolute value of heteroplasmy at each site and finding the
average across the entire mtgenome of the replicate differences (Table 15). The difference
between the highest and lowest error rate found was 0.000078 or 0.0078%. As there was
little variability between replicates, we established our sequencing error rate to be

36

0.000147 or .0.015%, the highest error rate found out of all our replicate samples. We
observed a much lower error rate compared to our preliminary investigation by using
improved techniques and increase sample size.
Additionally, we profiled the top ten sites with the greatest heteroplasmic variance
between replicates (Table 16). Three out of five of our replicate samples top sites of
variance were entirely within non-coding D-loop of the mtgenome, the most polymorphic
region of the genome. Of the two other replicates investigated with highly variable sites
in encoding regions, the WIK replicate had the highest frequency at 7.6% at the top site;
however, this location, 10535, was found to be strain specific and the top heteroplasmic
site across all WIK samples sequenced along with the other highly variable sites listed
within this strain.
Through target enrich we were able to obtain highly pure mtDNA for sequencing.
Sequencing artifacts (eg, adaptor dimers) that could typically compromise actual
heteroplasmic calls were filtered out through selection with AMPure bead clean-up. The
addition of paired-end molecular barcodes to adaptor sequences along with at or above
target fragment length increased our confidence in read quality and alignment strength of
our 100bp length reads. To ensure our identification of heteroplasmic sites was the result
of actual allelic variants and not an artifact, we established our heteroplasmic threshold as
5x our established error rate (0.0015%) at 0.075%. All considered along with our depth of
coverage, we still set a conservative threshold for resolving actual structural variants,
allowing for confidence in heteroplasmic calls. Our threshold was applied to all samples
and any sites with allele frequencies above were considered heteroplasmic sites
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Ameur et al. (2011) estimated point mutation frequency by looking at mutations
per nucleotide and finding the median, reporting a standing frequency of 0.000130.00018 in wild-type mice and 0.0012 in mutator mice expressing a proof-readingdeficient mtDNA polymerase (Ameur et al., 2011). Additionally, He et al. (2010)
established heteroplasmic variants 2x their established error rate when comparing tumor
to normal cells in humans (He et al., 2010).
We sequenced mtgenomes from 5 females and 5 males from three strains of
zebrafish. Using a heteroplasmic threshold of 0.075% (Figure 18), we saw no differences
between standing rates of heteroplasmy between males and females within the same
strain or between strains (Figure 19; left side). Additionally, we saw no differences
between standing rates of heteroplasmy over 0.075% when males and females were
pooled and strains were compared, AB-2077, Tu-1536, WIK-2289 sites (Figure 19; right
side).
Within strain and pair comparisons of heteroplasmic sites at >0.075% showed the
standing heteroplasmic frequency of the maternal lines relative to control and treated fullsibs of that line (Figures 20-22). In each strain we see the frequency of heteroplasmy
between control groups reflective of standing maternal heteroplasmy and a general
increase in the 10ng EE2/L treated fish. Heteroplasmy in maternal lines (Figure 23) is
consistent across strains, similar to what was seen in baseline fish comparisons.
When we compare treatment vs control of each pair/strain (Figure 24), a
statistically significant difference between control and treated is seen within one
pair/strain combo, 8-3ab; however although it is not statistically significant, there is a
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consistent trend across all strains and pairs demonstrating an increase in heteroplasmy
between treatment and control.
Comparing pooled control fish to pooled 10ng EE2/L treated fish (Figure 25), we
see a statistically significant difference between heteroplasmic variants at our determined
threshold (p<0.05), 2442±439 vs 4462±918. In our final comparison of heteroplasmy
between all groups: control, 10ng EE2/L treated, baseline and maternal (Figure 26), as
before we see statistically significant differences between control vs treated but also
between 10ng EE2/L treated vs baseline groups. This is not seen between baseline and
control or maternal and control. There was also no difference between maternal and any
other group however a sample size of only 5 fish appears to limit this comparison to the
maternal group while each other had a sample size of 30.
Within the vertebrate mtgenome, hypervariable sites exist predominantly within
non-coding regions (i.e., the d-loop). Ameur et al. defined sites with single nucleotide
variant frequencies (SNV) >0.5% as mutational hotspots, a value also used in both mouse
and human heteroplasmic studies. We found 1-30% of our heteroplasmic sites to fall in
this category. By this definition, we saw no clear differences between mutational hotspots
in treated vs untreated fish within the acute exposure sequencing group.
The goal of this study was to examine the effects of environmentally relevant
concentrations of EE2 on three common strains of zebrafish at the life cycle stage of
sexual differentiation. Our results show two out of three concentrations of EE2 (100ng
and 250ng EE2/L) were lethal to all three strains of zebrafish during this stage of
development. Consistent with other studies, we found exposure to EE2 during sexual
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differentiation increased the proportion of females relative to control groups; however
this was not statistically significant. Given that we could only compare the lowest
concentration of EE2 (at 10ng EE2/L) to the control to assess female proportion, we were
limited in our comparison across multiple treatment groups.
Our sequencing results using SureSelect Target Enrichment for mtDNA selection
shows ultra-high sequencing coverage with an average of 90,000x across our sequenced
samples giving us confidence in our heteroplasmic calls. Our use of sequencing five
replicate samples and unique lane design allowed us to establish an error rate of 0.015%
and determine a conservative heteroplasmic threshold of 0.075%. Using this threshold,
we compared heteroplasmic calls within and between strains. Our results show an
increase in heteroplasmic sites both within and between strains in 10ng EE2/L treated fish
compared to control; however, the level was not statistically significant. Comparison of
all treated to untreated fish shows a statistically significant difference between the groups.
The loss of two out of three of our treatment groups during exposure greatly
limited our comparisons of heteroplasmy between treated and untreated fish. With our
current results indicating an overall increase in heteroplasmy between 10ng EE2/L treated
fish compared to control fish, continued assessment of these effects are necessary. The
above assessment is important for understanding the vulnerability of the mitochondrial
genome to toxicant exposure. Are higher concentrations at different life stages susceptible
to similar effects? Although the exact mechanisms by which this occurs is still unknown,
determining the extent of genomic changes to the mitochondrial genome after EE2
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exposure is the first step in determining whether mtDNA can be a target of
xenoestrogens. If so, to what extent can these changes alter mitochondrial function?
Figures and Tables

Figure 7: Diagram of exposure system used to treat zebrafish to 17-α ethynylestradiol (black arrows
represent circular flow of exposure water, red arrows represent outflow of waste water, colored fish
bowls represent three strain designations.)

Figure 8: Acute exposure design. Three EE2 treatment groups (10, 100, 250ng EE2/L) and one
methanol control group, three zebrafish strains (AB, Tu, WIK), two breeding pairs per strain to create
full-sib starts. Six week exposure duration starting at 6 weeks of age.
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Table 2: Acute exposure (2) sequencing sample key
Maternal

Treated

ID

Full-sib ID

1-1abf

1-1ab

8-3abf

8-3ab

2-1tuf

2-1tu

7-3tuf

7-3tu

1-1wikf

1-1wik

1-2wikf

1-2wik

MeOH
cntrl
10ng
EE2/L
M
10M
10M
10M
10M
10M
10-

Baseline
# ID

Baseline

ID#

AB

1-5

1-6

sex

f

1-6

m

1-6

f
Tu

1-5

1-6

m

1-6

f
WIK

1-6

1-5
m

Acute treatment (2) sequencing sample key breakdown. Maternal line: pair ID, strain, f (female).
Treated fish: pair ID, strain, [either] M (methanol control) or 10- (10ng EE2/L tx), 1-6 (individual ID).
Baseline fish: strain, 1-5 (individual ID), [either] f (female) or m (male).
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Figure 9: Percent survival against 42 day treatment duration. Two acute exposure series were
performed (1) and (2) of control (a) group (with ≤0.00025% methanol, representing the greatest
amount of methanol used as an EE2 solvent in highest treatment) of three zebrafish strains: AB
(green), Tu (blue), and WIK (orange). Two maternal/paternal pairs were used per strain to generate
full-sib offspring represented by two shades of associated color (ie dark blue for pair one and light
blue for pair two of Tu). Maternal/paternal (m/p) lines used in acute exposure (1) were different than
m/p lines used in (2).
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Figure 10: Percent survival against 42 day exposure (1) and (2) for 10ng EE2/L treatment groups of
three zebrafish strains: AB (green), Tu (blue), and WIK (orange) from two pairs per strain.
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Figure 11: Percent survival against 42 day exposure (1) and (2) for 100ng EE2/L treatment groups of
three zebrafish strains: AB (green), Tu (blue), and WIK (orange) from two pairs per strain.
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Figure 12: Percent survival against 42 day exposure (1) and (2) for 250ng EE2/L treatment groups of
three zebrafish strains: AB (green), Tu (blue), and WIK (orange) from two pairs per strain.
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Figure 13: Proportion female between control and 10ng EE2/L treated fish after 42 day exposure
(p<0.05).

BETWEEN RUN PRECISION & ACCURACY
ng/L
ng/L
%
% differ
nominal
mean calc SD
RSD accuracy
1.0
1.0
0.2 19.0%
105%
2.5
2.0
0.3 14.3%
81%
10.0
11.6
1.9 16.1%
116%
50.0
49.3
8.2 16.5%
99%
100.0
97.2 17.0 17.4%
97%
250.0
248.7 22.9 9.2%
99%
WITHIN RUN PRECISION & ACCURACY
ng/L
ng/L
%
% differ
nominal
mean calc SD
RSD accuracy
1.0
1.1
0.1 8.0%
109%
2.5
2.3
0.3 11.8%
92%
10.0
9.6
0.8 8.3%
96%
50.0
47.3
2.5 5.2%
95%
100.0
111.2
6.7 6.0%
111%
250.0
242.0 18.0 7.4%
97%
Table 3: Between and within run precision and accuracy for acute exposure (2) calibrants and high-low
QCs.
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250ng/L
100ng/L
10ng/L

mean
228.983
122.164
15.580

SD
134.9086
18.55928
9.510547

RSD
58.9%
15.2%
61.0%

n=5
n=4
n=5

Table 4: Calculated mean concentrations of EE2 in mixing tank samples from acute exposure (2).

Figure 14: Gel verification examples showing samples post-sonication to ensure target fragment size of
150-200bp was achieved. Far left lane, 100bp ladder counting from the bottom up: 100, 200, 300,
400bp.

Figure 15: Bioanalyzer results during quality control check of post-sonication and post-AMPure
bead clean-up 1 for library preparation of earliest samples (7-3tuM set) against 100bp ladder.
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Table 5: Average sequence coverage for acute exposure (2)
per maternal sample
Maternal ID

coverage

1-1abf

82567

8-3abf

78815

7-3tuf

94984

1-1wikf

74776

1-2wikf

91816

Table 6: Average sequence coverage for acute exposure (2) AB pairs
Sample
ID

coverage

Sample
ID

coverage

Sample
ID

coverage

Sample
ID

coverage

1-1abM1

91037

1-1ab101

94143

8-3abM1

50489

8-3ab10.1

47506

1-1abM2

93196

1-1ab102

90290

8-3abM2

90640

8-3ab10.2

55063

1-1abM3

96062

1-1ab103

91187

8-3abM3

95426

8-3ab10.3

97797

1-1abM4

83178

1-1ab104

96033

8-3abM4

92141

8-3ab10.4

93809

1-1abM5

83372

1-1ab105

94783

8-3abM5

95692

8-3ab10.5

91471

1-1abM6

94503

1-1ab106

96294

8-3abM6

94090

8-3ab10.6

95028

Table 7: Average sequence coverage for acute exposure
(2) Tu pair
Sample ID

coverage

Sample ID

coverage

7-3tuM1

92037

7-3tu10-1

94186

7-3tuM2

90003

7-3tu10-2

94150

7-3tuM3

94058

7-3tu10-3

93702

7-3tuM4

88071

7-3tu10-4

74148

7-3tuM5

92173

7-3tu10-5

88435

7-3tuM6

90252

7-3tu10-6

94844
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Table 8: Average sequence coverage for acute exposure (2) WIK pairs
Sample
ID

coverage

Sample
ID

coverage

Sample
ID

coverage

Sample
ID

coverage

11wikM1

93145

11wik10-1

94683

12wikM1

94996

12wik10-1

95182

11wikM2

94030

11wik10-2

95744

12wikM2

93616

12wik10-2

93780

11wikM3

95093

11wik10-3

95843

12wikM3

92525

12wik10-3

89616

11wikM4

94538

11wik10-4

95749

12wikM4

94271

12wik10-4

95885

11wikM5

85296

11wik10-5

95801

12wikM5

92849

12wik10-5

92796

11wikM6

95226

11wik10-6

95454

12wikM6

96144

12wik10-6

95890

Table 9: Average sequence coverage for baseline fish
Sample ID

coverage

Sample ID

coverage

Sample ID

coverage

ab1f

94627

tu1f

91613

wik1f

94509

ab2f

76843

tu2f

89338

wik2f

94233

ab3f

81699

tu3f

91462

wik3f

96490

ab4f

91078

tu4f

90188

wik4f

92016

ab5f

95675

tu5f

87682

wik5f

97850

ab1m

91327

tu1m

80310

wik1m

79232

ab2m

73759

tu2m

82806

wik2m

68031

ab3m

84021

tu3m

89455

wik3m

79096

ab4m

81127

tu4m

39080

wik4m

90175

ab5m

92975

tu5m

91244

wik5m

93883
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Figure 16: Replicates overlaid sequence coverage to demonstrate general trend of coverage across
mtgenome. Each sample is associated strain color (AB-green, Tu-blue, WIK-orange) with grey for
same sample replicate data. Linear lines represent average sequence coverage.
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Table 10: Alignment scores for AB acute exposure sequencing samples
AB control ID

Total reads

Percent
aligned to
mtgenome

AB 10ng EE2/L
ID

Total reads

Percent
aligned to
mtgenome

1-1abM1

9785469

97.15%

1-1ab10-1

18649660

98.35%

1-1abM2

10307998

97.55%

1-1ab10-2

10046209

92.18%

1-1abM3

14540774

97.30%

1-1ab10-3

8392656

97.60%

1-1abM4

9227333

78.14%

1-1ab10-4

12932520

98.31%

1-1abM5

7497260

96.41%

1-1ab10-5

12384164

82.28%

1-1abM6

15135670

98.24%

1-1ab10-6

13416254

95.35%

8-3abM1

10327609

96.64%

8-3ab10-2

9041167

88.27%

8-3abM2

15593195

98.10%

8-3ab10-2

10849477

77.96%

8-3abM3

12370702

98.55%

8-3ab10-3

46985325

98.37%

8-3abM4

12545758

96.91%

8-3ab10-4

48892407

96.54%

8-3abM5

12833063

96.59%

8-3ab10-5

46088237

95.95%

8-3abM6

11075324

97.53%

8-3ab10-6

25023956

94.49%

Sequence alignment overview including total reads and percent reads aligning to mtgenome per
sample.
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Table 11: Alignment scores for Tu acute exposure sequencing samples
Tu control ID

Total reads

Percent
aligned to
mtgenome

Tu 10ngEE2/L
ID

Total reads

Percent
aligned to
mtgenome

7-3tuM1

9996541

96.22%

7-3tu10-1

12202077

96.38%

7-3tuM2

9380990

95.24%

7-3tu10-2

10783675

95.32%

7-3tuM3

12103602

97.89%

7-3tu10-3

9709533

96.51%

7-3tuM4

8837643

88.90%

7-3tu10-4

12448650

76.17%

7-3tuM5

9372289

96.82%

7-3tu10-5

13161170

94.65%

7-3tuM6

9195572

97.59%

7-3tu10-6

10863646

96.79%

7-3tuM2 REP

13484344

95.12%

7-3tu10-1-REP

14157961

96.52%

Sequence alignment overview including total reads and percent of reads aligning to mtgenome per
sample.
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Table 12: Alignment scores for WIK acute exposure sequencing samples
WIK control
ID

Total reads

Percent
aligned to
mtgenome

WIK 10ngEE2/L
ID

Total reads

Percent
aligned to
mtgenome

1-1wikM1

11483722

97.65%

1-1wik10-1

17343530

94.73%

1-1wikM2

13647048

95.32%

1-1wik10-2

22664699

97.95%

1-1wikM3

13007021

97.52%

1-1wik10-3

15159812

98.46%

1-1wikM4

12026852

87.34%

1-1wik10-4

13131655

96.35%

1-1wikM5

8499963

96.97%

1-1wik10-5

12758576

91.01%

1-1wikM6

11600664

95.40%

1-1wik10-6

15418596

97.06%

1-2wikM1

12591621

96.75%

1-2wik10-1

13475882

97.80%

1-2wikM2

13081604

96.62%

1-2wik10-2

13582151

92.57%

1-2wikM3

8791778

97.74%

1-2wik10-3

9741137

91.16%

1-2wikM4

10431192

98.10%

1-2wik10-4

11695032

97.43%

1-2wikM5

9229908

96.36%

1-2wik10-5

10221356

97.70%

1-2wikM6

13149401

97.70%

1-2wik10-6

13164686

97.80%

1-2wik10-3-REP

8390810

96.71%

Sequence alignment overview including total reads and percent of reads aligning to mtgenome per
sample.
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Table 13: Alignment scores for baseline sequencing samples

AB ID

Total
reads

Percent
aligned
to mt
genome

ab1f

11997623

96.33

tu1f

9770625

98.05

wik1f

17152404

97.46

ab2f

6748448

97.09

tu2f

10730290

97.96

wik2f

12065535

97.10

ab3f

8431181

98.28

tu3f

10937490

98.52

wik3f

25447115

98.85

ab4f

9358941

93.32

tu4f

10048129

97.68

wik4f

9592859

96.45

ab5f

48378428

98.58

tu5f

9698742

96.10

wik5f

75301641

98.49

ab1m

9919322

97.73

tu1m

8152350

98.02

wik1m

8304676

94.49

ab2m

7485225

96.14

tu2m

7482459

96.16

wik2m

6844795

94.96

ab3m

8713971

94.45

tu3m 11928427

97.86

wik3m

9489164

97.16

ab4m

10804879

70.17

tu4m 30001454

97.96

wik4m 12682535

97.71

ab5m

14160408

97.09

tu5m 11999388

97.16

wik5m 14932480

97.24

ab4mREP

7444162

96.18

ab4fREP

7936482

98.00

Tu
ID

Total
reads

Percent
aligned to
mtgenome

WIK
ID

Total
reads

Percent
aligned
to mt
genome

Sequence alignment overview including total reads and percent of reads aligning to mtgenome per
sample.
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Table 14: Alignment scores for maternal sequencing samples
Maternal ID

Total reads

Percent aligned to
mtgenome

1-1abf

8049851

94.12%

8-3abf

7722668

93.41%

2-1tuf

n/a

n/a

7-3tuf

10166509

97.65%

9261831

97.03%

1-1wikf
1-2wikf

Sequence coverage overview including total reads and percent of reads aligning to mtgenome per
sample.
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Figure 17: Linear regression of sequencing replicate heteroplasmy representing each strain (AB, Tu,
and WIK), same vs different sequencing lanes between replicates, and differing groups (baseline,
treated, and control).
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Table 15: Comparison of replicate samples sequencing design and values
Replicate Sample
Lane design
Group
Average error Greatest error
ID
Control
7-3tuM2
0.000069
0.0096
Same lane
Treated
7-3tu10-1
0.000104
0.029
Treated
1-2wik10-3
0.000147
0.076
Different lane
Baseline
ab4f
0.000102
0.00037
Baseline
ab4m
0.000121
0.0079

Table 16: Top ten sites on mtgenome with greatest heteroplasmic variance between
replicates
Site

7-3tuM2

7-3tu10-1

1-2wik10-3

ab4f

ab4m

1

850

824

10535

834

834

2

848

828

878

841

878

3

834

825

870

843

804

4

870

827

834

836

870

5

827

837

13274

878

813

6

825

833

6265

844

13202

7

828

839

6176

908

855

8

878

834

11293

825

4399

9

824

846

11134

804

896

10

839

843

5676

828

843

Top ten sites on mtgenome with greatest rate of heteroplasmic variance between replicate samples.
Sites highlighted in grey represent coding regions on the mtgenome.
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Figure 18: Breakdown of heteroplasmic sites ≥0.075% per individual of baseline fish, strains AB
(green), Tu (blue) and WIK (orange).
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Figure 19: Breakdown of heteroplasmic sites ≥0.075% in baseline fish, strains AB (green), Tu (blue)
and WIK (orange) either grouped by sex (left chart) or pooled sex (right chart).
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Figure 20: Breakdown of heteroplasmic sites ≥0.075% in maternal, MeOH control fish and 10ng
EE2/L treated fish of two different AB pairs (1-1 left and 8-3 right).
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Figure 21: Breakdown of heteroplasmic sites ≥0.075% in maternal, MeOH control fish and 10ng
EE2/L treated fish of Tu pair 7-3.
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Figure 22: Breakdown of heteroplasmic sites ≥0.075% in maternal, MeOH control fish and 10ng
EE2/L treated fish of two different WIK pairs (1-1 left and 1-2 right).
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Figure 23: Breakdown of heteroplasmic sites ≥0.075% in maternal fish by pair and strain (AB pairs in
shades of green, Tu in blue, and WIK pairs in shades of orange).
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Figure 24: Breakdown of heteroplasmic sites ≥0.075% in control (no pattern) vs EE2 treated fish
(block patterned) pair and strain (AB pairs in shades of green, Tu in blue, and WIK pairs in shades of
orange).
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Figure 25: Breakdown of heteroplasmic sites ≥0.075% in MeOH control vs 10ng EE2/L treated fish
with strains pooled (p=0.03).
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Figure 26: Breakdown of heteroplasmic sites ≥0.075% in each pooled group: MeOH control, 10ng
EE2/L treated, baseline males and females, and maternal lines with 95% CI.
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Chapter IV: Chronic treatment study
Introduction
Environmental estrogens are a potent class of toxicants found ubiquitously in our
environment as a result of their wide range of uses in commercial and industrial products
including pesticides, plastics, and pharmaceuticals (Fenske et al., 2005; Ropero et al.,
2006). Environmental estrogens present a significant health concern as numerous studies
have demonstrated synthetic estrogens modulate and/or disrupt a variety of animal
systems (Hecker & Hollert, 2011). Such studies demonstrating physiological and
developmental dysfunction on both aquatic and terrestrial vertebrate species within
environmentally relevant concentrations include: reduced sperm production, altered
spermantogenesis, intersex and complete feminization of males, altered female oogenesis
and induction of aneuploidy in both sexes (Brown et al., 2008; Hunt et al., 2003; Kidd et
al., 2007; Schultz et al., 2003; Takahashi & Oishi, 2006; Tyler & Jobling, 2008).
Despite it being widely accepted environmental estrogen exposure has the ability
to interfere with a variety of vertebrate organ system, the extent of these effects are
continually being investigated. Of these, the investigation of mitochondria as targets of
toxicant exposure is of great concern as these organelles are responsible for cellular lifedeath decisions and also play critical roles in many other physiological processes (Cheng
& Ristow, 2013). With specific concern for mtgenome susceptibility from environmental
estrogen exposure, we aimed to continue our investigation on the effects of 17αethynylestradiol (EE2) exposure on mitochondrial genome stability.
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The objective of this study was to further investigate the effects of chronic
exposure to the common environmental estrogen EE2 on mitochondrial DNA (mtDNA)
stability in zebrafish from embryonic development through reproductive maturity. The
current challenge of sequencing studies is often dependent on project funding.
Unfortunately, financial constraints limited this study from being carried through
completion of DNA sequencing and analysis; however, concerning effects of the test
compound on common fish development, life cycle and sex determination were observed.
Methods
All fish were maintained in accordance to guidelines established by the
Institutional Animal Care and Use Committee (IACUC) of Portland State University.
Adult male and female zebrafish for generation of embryos used in chronic exposure, of
the three common laboratory strains AB, Tu, and WIK, less than one year of age were
obtained from the Zebrafish International Resource Center (ZIRC). Fish were housed in
2.8-liter baffled flow-through tanks at a ratio of 1 male: 1 female with a stocking density
of 10 or less fish per 2.8L tank in the Brown Zebrafish Aquatics Facility at Portland State
University.
Fish were maintained on the Aquaneering Modular System with 4-stage central
filtration providing continuous flow-through of recirculating water with a twice daily
automated 10% water change. This system monitors parameters to stay within a narrow
range. Aquatic facility had a photo period of 15h light: 9 hr dark. Fish were fed two times
a day ad libitum with manufactured larvae power and live Artemia salina (brine shrimp).
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Sexually mature zebrafish ~1 year of age were set up as breeding pairs (1 male:1
female) in Aquaneering Crossing Tanks with dividers to separate each pair. The following
morning, dividers were removed and zebrafish were allowed to spawn for up to 5 hours.
Spawning occurred within the aquatic facility using system water.
The test compound 17α-ethynylestradiol (EE2) was obtained from Sigma-Aldrich
(≥ 98% grade). EE2 was solubilized in 100% methanol at a ratio of 1mg/1mL. A final
working concentration of 1ng EE2/µL in 10% methanol was prepared as the final
exposure working stock for spiking treatment water. Control fish were exposed to
methanol at the highest EE2 treatment concentration, 5µL 100% methanol/liter tank
water or ≤0.0005%.
1-L amber glass bottles were filled with embryo media and spiked with EE2
working stock at respective treatment concentration 24-hours prior treatment start.
Embryos were collected within 6 hours of morning divider removal and rinsed with
untreated embryo media (Cold Harbor Springs 60x recipe). At a stocking density of ≤50
embryos per petri dish, embryos were submersed in pre-mixed treatment water from one
of five treatment groups: control, 1, 10, 25 or 50ng EE2/L. Petri dishes were placed in an
incubator at 28°C for 5 days. Non-viable embryos were pulled and counts were recorded
daily along with 2 water changes within the first five days post fertilization (dpf).
At 5 dpf, hatched larvae were transferred to 600mL glass beakers in pre-mixed
respective exposure water and started on concentrated rotifers twice daily ad libitum. Full
sib, same strain, grouped larvae were housed in 600mL beakers until 6 weeks of age with
water changes every other day of pre-mixed exposure water. At 9dpf larvae were
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transitioned to live brine shrimp in addition to rotifers. Larval powder was introduced at
14 dpf. Fish were transitioned to powder only at 3 weeks and raised under these
conditions until 6 weeks of age.
The exposure system used was as described in chapter III methods, acute
exposure design. At six weeks of age, 20 full-sibs of each pair/strain/treatment were
transferred to exposure system 1 gallon fish bowls. Common 20-gallon mixing tanks for
respective treatments were filled and spiked with EE2 24-hours prior to transfer.
Exposure to all fish at 50ng EE2/L was terminated after 6 weeks due abnormal growth
patterns and impaired development. The remaining treatment groups: control, 1, 10, and
25ng EE2/L were continued until 6 months of age.
Fish were housed on the exposure system until 6 months of age. 30-second
flushes refreshed water every other day. Waste debris was removed via turkey baster. Fish
were maintained on a standard adult feeding schedule using fish powder ad libitum, twice
daily.
At the 6 week transfer only 20 fish per strain/pair/treatment were continued
through the 6 month exposure. Remaining fish were raised in 600mL beaker conditions
until 8 weeks of age for histological examination of gonadal tissue. At 8 weeks of age,
juvenile larvae were euthanized in MS-222 (Sigma-Aldrich) at 300mg/L water at pH 8
for ≥15 minutes after fasting for 24 hours. Fish were transferred to 10% neutral buffered
formalin (Sigma-Aldridge) for ≥24 hours for fixation. Fixed fish were washed in 70%
ethanol and transferred to embedding cassettes stored in 70% ethanol for further
processing. Samples were sent to the Oregon Health and Science University,
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Histopathology Shared Resource Center where fish were paraffin embedded, sectioned
onto slides using mid-sagittal cuts and H&E stained.
After 6 months of exposure, fish were euthanized using MS-222 at a
concentration of 300mg/L water at pH 8 for ≥15 minutes. Weight and sex was recorded
prior to liver excision. Liver tissue was collected from zebrafish by surgical manipulation
under a stereoscopic microscope (Leica Microsystems) and stored at -20°C for further
use.
Exposure water samples (100mL) were collected monthly throughout exposures.
Control water samples (100mL) were collected at the start, half-way and final month time
points. Both exposure and control samples were immediately spiked with two internal
standards (10ng/L). Samples were stored at 4°C until further analysis.
The following compounds were used for LC-MS evaluation: 17α-ethynylestradiol
(EE2) was obtained from Sigma-Aldrich. Formic acid, methanol (LC-MS grade) and
water (LC–MS grade) were from Burdick and Jackson (Muskegon, MI). 17β-Estradiol16, 16, 17-d3 (E2D3) was from Toronto Research Chemicals Inc. 17α-Ethynylestradiol2,4,16,16-d4 (EE2D4) was from CDN Isotopes.
Calibrators were generated to cover the concentration range of EE2 in mixing
tank water from 0.1ng-100ng EE2/L using dilutions of authentic standard dried and
derivatized using 1:1 100µl dansyl chloride in acetone and 100µl sodium bicarbonate
incubated at 60°C for 4 mins, cooled to room temperature as starting mobile phase.
LC–ESI-MS analyses were performed using a high-resolution (30,000) Thermo
LTQ-Orbitrap Discovery hybrid mass spectrometry instrument (San Jose, CA) equipped

69

with an electrospray ionization source operating in the positive mode. The ESI interface
using the following settings: sheath gas flow rate 40 (arbitrary units), aux gas flow rate 15
(arbitrary units), spray voltage 2kV, capillary temperature 250C, capillary voltage -17 V,
and tube lens voltage -85 V. The Orbitrap was externally calibrated prior to data
acquisition allowing accurate mass measurements for [M+H]+ or [M-H]- ions to be
obtained to within 4ppm.
The Orbitrap was coupled to a Thermo Accela HPLC system. EE2 was resolved
using a Kinetex C18 (4.6x50mm, 2.1 mm i.d., 2.5uL particle size) HPLC column with
guard cartridge (Phenomenex; Torrance, CA). Mobile phases consisted of 0.1% formic
acid in HPLC grade water (A), 0.1% formic acid in acetonitrile (CAN) (B). The gradient
mobile phase was delivered at a flow rate of 0.3 mL/min and the formic:water mobile
phase.
Start conditions were 30% B, increased to 98% B over 7 minutes, decreased to
30% B over the next 2.5 minutes, 100% B over the next three minutes. Column was
washed at 100% B for 1 minute and back to 30% B for 5 minutes. The column
temperature was kept at 50°C using a thermostatic column oven. The sample injection
volume was 20 μL.
Results and Discussion
We exposed 6 groups of full-sib offspring from 3 strains of zebrafish: AB, Tu, and
WIK, across 5 treatment categories: 1ng, 10ng, 25ng, 50ng EE2/L and control (methanol
≤0.0005%) to assess the effects throughout development and maturation, embryos to 6
months. Survival curves and sex ratios were examined after 6 month exposure. At 8
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weeks of age, a portion of juveniles were partitioned off to examine the gonadal tissue
after exposure from fertilization through sexual differentiation.
We were interested in comparing the survivorship of each treatment type (1ng,
10ng, 25ng, and 50ng EE2/L) to control (≤0.0005% methanol) using three zebrafish
strains (AB, Tu and WIK) from fertilization through 6 week exposure then continued
from 6 weeks to 6 month exposure.
Survivorship from fertilization through 6 weeks of exposure are shown for all
treatment types: control, 1ng, 10ng, 25ng, and 50ng EE2/L (figure 27); however, the 50ng
EE2/L treated fish for all strains and pairs had impaired growth with survival lower than
80% in 4 of 6 groups (pair/strain combo). Therefore the 50ng EE/L treatment was
terminated at 8 weeks for all strain/pair combos as fish to prevent pain and suffering of
surviving fish. In general the surviving fish did not appear healthy and exhibited (put
abnormal traits observed here).
In all treatment groups, unaccounted loss (i.e., missed counts on tiny larvae and/or
cannibalism) were shown on the last day of exposure. The greatest loss in all treatments
occurred within the first 10 days post fertilization which is attributed to normal larval
mortality. Control fish from 0-6 weeks had varied survival; however after 10 days post
fertilization, the most fragile period of development, no strain/pair combo had greater
than 10% loss over multiple day periods and loss beyond that was accounted for at the
end of the 6 weeks. Similar patterns occurred from 0-6 weeks in 1ng, 10ng and 25ng
EE2/L treatment groups; most loss occurring within the first 10 days and other major
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losses shown at the end of the 6 week survivorship attributed to miscounts and/or
cannibalism.
For the 6 week-6 month survival curves, 20 fish per tank were added and we
therefore reset the percentage to 100%. Survival during this period was consistent across
all tanks and strains (Figures 27-31). As in the 0-6wks survival curves, any miscounts are
demonstrated at the end of the 180 day exposure which was <10% across all treatments.
Among all strains and treatments a near 100% survival was observed. The exception to
this was the 25ng EE2/L treated fish which exhibited between 70-90% survival in all
strain/pair combos except 1, TuCH1. Phenotypically, 25ng EE2/L fish appeared to have
similar appearance to other treatments despite survival patterns not demonstrating a
similar pattern.
Among the 50 ng EE2/L treatments, the greatest loss occurred weeks 6 and 7. No
outstanding differences were observed between strains, but the 50 ng EE2/L treated fish
were not developing normally so treatments were terminated despite the absence of major
losses to prevent undue pain and suffering. The greatest losses in the full exposure
treatments from 6wks-6months occurred in the 25ng EE2/L despite no outwardly
apparent developmental abnormalities and normal growth.
When evaluating the sex ratios among the surviving treatments, a trend was
observed. The proportion of females increased along with treatment level (i.e., 1ng, 10ng,
and 25ng EE2/L) compared to control (Figure 32). These differences resulted in a
statistically significant difference in the proportion of females between control and 10ng
EE2/L treated and control and 25ng EE2/L treated.
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Gross images were taken prior to fixation for histological processing to
demonstrate morphological differences seen between control and treatment groups
(Figures 33-36). Assessing three phenotypic categories, reduced body size, edema in
body cavity and bulging eye (as seen in highest acute exposure treatment groups), we see
that the 25ng and 50ng EE2/L treatment groups display abnormal growth patterns
compared to control, 1ng and 10ng EE2/L treatments (Table 17) which is supported by
our survival curves.
During processing, chemical resistant marker was used for labeling of cassettes;
however, xylene used during processing resulted in loss of sample identification. No
results can be reported on the whole fish mid-sagittal sections; however the slides were
still assessed and general unique characteristics were seen. We observed distinct
differences between slides including intersex gonadal tissue (Figure 38). In addition, we
observed differential H&E staining uptake demonstrated in male liver tissue between
males exposed to estrogen vs unexposed (Ven et al., 2003). We observed similar
proportions of male liver tissue with basophilia as EE2 treated proportions sent for
histological processing.
Analysis of samples showed contamination which was sourced to be within the
100% methanol used for LC-MS specific solubilization. Samples could not be used for
further analysis because this was the methanol stock used to prepare LC-MS EE2 and
internal standard stocks; however, this was not the methanol used to prepare working
EE2 stocks for spiking common mixing tanks. Despite contamination, we did find the
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dansyl chloride derivatization method to be much more effective in increasing sensitivity
to EE2 quantification.
As a result of funding, we were unable to carry samples through library
preparation and sequencing as described in chapter II; however, samples are being stored
at -20°C for future evaluation of the effects of chronic EE2 treatment from embryonic
development through 6 months of age. We observed treatment specific effects despite not
being able to analysis chronic treatment of EE2 on mitochondrial genome stability.
While we were not able to carry this study through its goal of examining the
effects of chronic exposure of environmentally relevant concentrations of EE2 on three
common strains of zebrafish from embryonic development to reproductive maturity, we
were still able to gain valuable information from the exposure series of 1, 10, 25, and
50ng EE2/L compared to our controls. Our results demonstrated normal development and
growth at 1, 10, and 25ng EE2/L while toxicity at 50ng EE2/L in developing zebrafish
was observed. We observed different female proportions between control versus our two
highest concentrations of EE2 treatment, 10ng and 25ng EE2/L. When these results are
taken into consideration with our acute exposure results of survivorship and female
proportions, it supports the necessity behind further investigation of EE2 treatments at
varied concentrations during different life stages of zebrafish development.
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Figures and Tables

Figure 27: Percent survival against 6 month exposure in 0dpf-6weeks (top) and 6weeks-6months
(bottom) for control groups of three zebrafish strains: AB (green), Tu (blue), and WIK (orange) from
two pairs per strain.
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Figure 28: Percent survival against 6 month exposure in 0dpf-6weeks (top) and 6weeks-6months
(bottom) for 1ng EE2/L treatment groups of three zebrafish strains: AB (green), Tu (blue), and WIK
(orange) from two pairs per strain.

76

Figure 29: Percent survival against 6 month exposure in 0dpf-6weeks (top) and 6weeks-6months
(bottom) for 10ng EE2/L treatment groups of three zebrafish strains: AB (green), Tu (blue), and WIK
(orange) from two pairs per strain.
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Figure 30: Percent survival against 6 month exposure in 0dpf-6weeks (top) and 6weeks-6months
(bottom) for 25ng EE2/L treatment groups of three zebrafish strains: AB (green), Tu (blue), and WIK
(orange) from two pairs per strain.
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Figure 31: Percent survival against 6 month exposure in 0dpf-6weeks for 50ng EE2/L treatment groups
of three zebrafish strains: AB (green), Tu (blue), and WIK (orange) from two pairs per strain.
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Figure 32: Proportion of females between control and 1ng, 10ng, and 25ng EE2/L treated fish after
6 month exposure starting from 5 hours post fertilization.
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Figure 33: Gross image via stereoscopic microscope camera of control (≤0.0005% methanol) larva at 8
weeks

Figure 34: Gross images via stereoscopic microscope camera of 50ng EE2/L treated larva at 8 weeks
demonstrating reduced body size and edema in body cavity.

Figure 35: Gross image via stereoscopic microscope camera of 10ng EE2/L treated larva at 8 weeks
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Figure 36: Gross image via stereoscopic microscope camera of 25ng EE2/L treated larva at 8
weeks

Figure 37: Gross images via stereoscopic microscope camera of 50ng EE2/L treated larva at 8 weeks
demonstrating reduced body size and edema in body cavity.
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Table 17: Control vs treated at 8 weeks, phenotypic comparison of 3 developmental categories

Phenotype

Control

1ng EE2/L

10ng EE2/L

25ng EE2/L

50ng EE2/L

Reduced body size

No

No

No

Yes

Yes

Edema in body cavity

No

No

No

No

Yes

Bulging eye

No

No

No

No

Yes

Figure 38: Histology image of intersex tissue from 8 week old (potentially EE2 exposed) fish larva
(red circle indicating an oocyte and black arrows indicating testicular tissue).
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Chapter V: Discussion
This project aimed to assess the effects of environmentally relevant
concentrations of 17α-ethynylestradiol on mitochondrial genome stability in the model
zebrafish. My central hypothesis was, “The environmental estrogen 17-α ethynylestradiol
increases mitochondrial DNA heteroplasmy.” Our investigation for testing this hypothesis
revealed novel aspects of mutation accumulation within trout and among three strains of
zebrafish evaluated. We demonstrated in two of our experimental investigations that
environmentally relevant, low level exposure to EE2 increases mitochondrial
heteroplasmy in two different species of fish. In addition to seeing effects on the
mtgenome, we saw that both acute and chronic exposure to EE2 had severe effects of
development and survival on zebrafish.
Further evaluation of this sequencing data is necessary to differentiate
nonfunctional consequences from functional consequences. Of these increased
heteroplasmic sites, which are associated directly to the exposure and of these which have
the potential to, or currently decrease, mitochondrial function? In addition, continued
investigation of environmental estrogen exposure on mtgenome stability is necessary for
understanding the effects of exposure as well as the possible initiation of human disease
state from exposure. We demonstrated that there is an overall increase in mitochondrial
heteroplasmy under environmentally relevant exposure regimes, but what are the
impactions for human health? Ultimately, can this eventually induce mitochondrial
disease states?
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The results of this investigation provide the framework for studies involving
toxicant exposure and mitochondrial genome stability. In this study we investigated a
single toxicant; however, both aquatic and terrestrial vertebrates, including humans are
exposed to a wealth of toxicants that have the potential to induce subtle and slow
mutations within the mitochondrial genome.
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